Busey Bank Purchases 401 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Busey Bank grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,514 shares of the company’s stock after purchasing an additional 401 shares during the quarter. Busey Bank’s holdings in GE HealthCare Technologies were worth $424,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Pathway Financial Advisers LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Fred Alger Management LLC bought a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $26,000. BNP Paribas bought a new position in GE HealthCare Technologies during the 1st quarter worth approximately $30,000. Elkhorn Partners Limited Partnership bought a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $31,000. Finally, Annapolis Financial Services LLC grew its position in GE HealthCare Technologies by 171.9% during the 1st quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock worth $32,000 after acquiring an additional 220 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 0.5 %

NASDAQ GEHC opened at $88.42 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.55. The firm has a market capitalization of $40.36 billion, a PE ratio of 25.85, a P/E/G ratio of 3.39 and a beta of 1.18. The stock’s 50 day moving average is $88.42 and its 200 day moving average is $83.45.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same period in the previous year, the company posted $0.92 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Analyst Upgrades and Downgrades

GEHC has been the topic of several recent research reports. Stifel Nicolaus raised their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Evercore ISI boosted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 target price on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.